Coccidioidomycosis (Infectious Diseases): Multimedia

References

1. Galgiani JN. Coccidioides Species. In: Principles and Practices of Infectious Diseases, Mandell, Douglas and Bennet. Vol 2. 6^th ed. Elsevier; 2005:3040-51.

2. Galgiani JN. Primary Coccidioidal Infection. UpToDate [serial online]. January 18, 2008;Accessed 2008. Available at www.uptodate.com.

3. Johnson RH, Caldwell JW, Welch G. The great Coccidioidomycosis epidemic: Clinical Features. In: Einstein HE, Catanzaro A, eds. Proceedings of Fifth International Conference. Bethesda, MD: 1996:77-87.

4. Richardson MD, Warnock DW. Coccidioidomycosis. In: Fungal Infection Diagnosis and Management. Blackwell Scientific Publication; 1993:134-42.

5. de Aguiar Cordeiro R, Nogueira Brilhante RS, Gadelha Rocha MF, Araujo Moura FE, Pires de Camargo Z, Costa Sidrim JJ. Rapid diagnosis of coccidioidomycosis by nested PCR assay of sputum. Clin Microbiol Infect. Apr 2007;13(4):449-51. [Medline].

6. Bialek R, Kern J, Herrmann T, Tijerina R, Cecenas L, Reischl U, et al. PCR assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen 2/proline-rich antigen. J Clin Microbiol. Feb 2004;42(2):778-83. [Medline].

7. Binnicker MJ, Buckwalter SP, Eisberner JJ, Stewart RA, McCullough AE, Wohlfiel SL, et al. Detection of Coccidioides species in clinical specimens by real-time PCR. J Clin Microbiol. Jan 2007;45(1):173-8. [Medline].

8. Tkachenko GA, Grishina MA, Antonov VA, Savchenko SS, Zamaraev VS, Lesovoi VS, et al. [Identification of the agents of coccidioidomycosis using polymerase chain reaction]. Mol Gen Mikrobiol Virusol. 2007;25-31. [Medline].

9. Ampel NM, Giblin A, Chavez S. Factors and outcomes associated with the decision to treat primary pulmonary coccidioidomycosis (abstract). San Diego, CA: Infectious Diseases Society of America 45th annual meeting; October 4-7, 2007.

10. Ampel N. Posaconazole for coccidioidomycosis. Journal Watch ID,. Aug 2007, CID Sep 2007.

11. Paugam A. [The latest data on posaconazole]. Med Mal Infect. Feb 2007;37(2):71-6. [Medline].

12. Nagappan V, Deresinski S. Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent. Clin Infect Dis. Dec 15 2007;45(12):1610-7. [Medline].

13. Stevens DA, Rendon A, Gaona-Flores V, Catanzaro A, Anstead GM, Pedicone L, et al. Posaconazole therapy for chronic refractory coccidioidomycosis. Chest. Sep 2007;132(3):952-8. [Medline].

14. Anstead GM, Corcoran G, Lewis J, Berg D, Graybill JR. Refractory coccidioidomycosis treated with posaconazole. Clin Infect Dis. Jun 15 2005;40(12):1770-6. [Medline].

15. Crum NF, Lederman ER, Stafford CM, Parrish JS, Wallace MR. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore). May 2004;83(3):149-75. [Medline].

16. Anthony S. Use of echinocandins (caspofungin) in the treatment of disseminated coccidioidomycosis in a renal transplant patient. Clinical Infectious Diseases. 2004;(39)6:879-880.

17. Park DW, Sohn JW, Cheong HJ, Kim WJ, Kim MJ, Kim JH, et al. Combination therapy of disseminated coccidioidomycosis with caspofungin and fluconazole. BMC Infect Dis. Feb 15 2006;6:26. [Medline].

18. Hsue G, Napier JT, Prince RA, Chi J, Hospenthal DR. Treatment of meningeal coccidioidomycosis with caspofungin. J Antimicrob Chemother. Jul 2004;54(1):292-4. [Medline].

19. Galgiani JN:. Vaccines to prevent systemic mycosis: holy grails meet translational realities. Editorial comment. JID2008:197 April 1..

20. Einstein HE, Johnson RH. Coccidioidomycosis: new aspects of epidemiology and therapy. Clin Infect Dis. Mar 1993;16(3):349-54. [Medline].

21. Arsura EL, Bobba RK, Reddy CM. Coccidioidal pericarditis: a case presentation and review of the literature. Int J Infect Dis. Mar 2005;9(2):104-9. [Medline].

22. Caldwell JW, Arsura EL, Kilgore WB, Garcia AL, Reddy V, Johnson RH. Coccidioidomycosis in pregnancy during an epidemic in California. Obstet Gynecol. Feb 2000;95(2):236-9. [Medline].

23. Arsura EL, Kilgore WB. Miliary coccidioidomycosis in the immunocompetent. Chest. Feb 2000;117(2):404-9. [Medline].

24. Arsura EL, Kilgore WB, Ratnayake SN. Erythema nodosum in pregnant patients with coccidioidomycosis. Clin Infect Dis. Nov 1998;27(5):1201-3. [Medline].

25. Blair JE, Douglas DD. Coccidioidomycosis in liver transplant recipients relocating to an endemic area. Dig Dis Sci. Nov-Dec 2004;49(11-12):1981-5. [Medline].

26. Crum NF. Voriconazole in combination with Amphotericin B for salvage therapy of coccidioidomycosis: case report and review of the literature. IDCP. July 2007;15(4):265-268.

27. Dewsnup DH, Galgiani JN, Graybill JR, Diaz M, Rendon A, Cloud GA, et al. Is it ever safe to stop azole therapy for Coccidioides immitis meningitis?. Ann Intern Med. Feb 1 1996;124(3):305-10. [Medline].

28. Galgiani JN. Coccidioidomycosis: a regional disease of national importance. Rethinking approaches for control. Ann Intern Med. Feb 16 1999;130(4 Pt 1):293-300. [Medline].

29. Galgiani JN, Ampel NM, Catanzaro A, Johnson RH, Stevens DA, Williams PL. Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis. Apr 2000;30(4):658-61. [Medline]. [Full Text].

30. Galgiani JN:. Manifestations and treatment of extrapulmonary coccidiodomycosis. 2008UpToDate, updated April 2006. http://utdol.com/utd/content/topic Primary manifestation of cocci updated. Sep 2007.

31. Mirels LF, Stevens DA. Update on treatment of coccidioidomycosis. West J Med. Jan 1997;166(1):58-9. [Medline].

32. Pappagianis D, Zimmer BL. Serology of coccidioidomycosis. Clin Microbiol Rev. Jul 1990;3(3):247-68. [Medline].

33. Prabhu RM, Bonnell M, Currier BL. Successful treatment of disseminated nonmeningeal coccidioidomycosis with voriconazole. Clin Infect Dis. 2004;39:74-77. [Medline].

34. Ragland AS, Arsura E, Ismail Y, Johnson R. Eosinophilic pleocytosis in coccidioidal meningitis: frequency and significance. Am J Med. Sep 1993;95(3):254-7. [Medline].

35. Stevens DA. Coccidioidomycosis. N Engl J Med. Apr 20 1995;332(16):1077-82. [Medline].

36. Stevens DA, Brummer E, Clemons KV. Interferon-gamma as an antifungal. J Infect Dis. Sep 15 2006;194 Suppl 1:S33-7. [Medline].

Further Reading

Keywords

coccidioidomycosis, primary pulmonary coccidioidomycosis, primary coccidioidomycosis, chronic coccidioidomycosis, valley fever, desert fever, San Joaquin Valley fever, California fever, Coccidioides immitis, C immitis, Coccidioides posadasii, C posadasii, desert rheumatism, cocci, coccidioidal granuloma, coccidioidal nodule, coccidioidal cavity, coccidioidal mycosis, coccidioidal meningitis, coccidioidal pneumonia

Contributor Information and Disclosures

Author

Edward L Arsura, MD, Chair, Department of Medicine, Chief Medical Officer, Richmond University Medical Center
Edward L Arsura, MD is a member of the following medical societies: American College of Physician Executives, American College of Physicians, American Federation for Medical Research, American Heart Association, American Medical Association, California Medical Association, Society of General Internal Medicine, and Southern Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Duane R Hospenthal, MD, PhD, Chief, Infectious Disease Service, San Antonio Military Medical Center, Brooke Army Medical Center; Professor of Medicine, Uniformed Services University of the Health Sciences
Duane R Hospenthal, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Armed Forces Infectious Diseases Society, Association of Military Surgeons of the US, Infectious Diseases Society of America, International Society for Infectious Diseases, International Society of Travel Medicine, and Medical Mycology Society of the Americas
Disclosure: Nothing to disclose.

Ana Paula Oppenheimer, MD, MPH,, Staff Physician, Department of Medicine, Richmond University Medical Center
Disclosure: Nothing to disclose.

Medical Editor

Thomas Herchline, MD, Professor of Medicine, Wright State University Boonshoft School of Medicine; Medical Director, Public Health, Dayton and Montgomery County, Ohio
Thomas Herchline, MD is a member of the following medical societies: American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Thomas M Kerkering, MD, Chief of Infectious Diseases, Virginia Tech, Carilion School of Medicine, Roanoke, Virginia
Thomas M Kerkering, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American Public Health Association, American Society for Microbiology, American Society of Tropical Medicine and Hygiene, Infectious Diseases Society of America, Medical Society of Virginia, and Wilderness Medical Society
Disclosure: Nothing to disclose.

CME Editor

Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital
Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital
Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America
Disclosure: Nothing to disclose.